drugset / Trial / NCT00371215
Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate whether rThrombin is safe when used for controlling bleeding during skin graft surgery.
Timeline
- Start
- 2006-08
- Primary completion
- 2007-06
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | rThrombin | Protein / enzyme biologic | 1000 iu | Topical |
Indications
No indication recorded.